Entity Details

Primary name APC2
Entity type gene
Source Source Link

Details

PrimaryID10297
RefseqGeneNG_055243
SymbolAPC2
NameAPC regulator of WNT signaling pathway 2
Chromosome19
Location19p13.3
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate1999-06-06
ModificationDate2021-06-20

Ontological Relatives

UniProt IDsAPCL_HUMAN

GO terms

Show/Hide Table
GOName
GO:0000226 microtubule cytoskeleton organization
GO:0001708 cell fate specification
GO:0005737 cytoplasm
GO:0005794 Golgi apparatus
GO:0005829 cytosol
GO:0005874 microtubule
GO:0005884 actin filament
GO:0007026 negative regulation of microtubule depolymerization
GO:0007389 pattern specification process
GO:0007399 nervous system development
GO:0008013 beta-catenin binding
GO:0008017 microtubule binding
GO:0015630 microtubule cytoskeleton
GO:0016055 Wnt signaling pathway
GO:0016342 catenin complex
GO:0016477 cell migration
GO:0030496 midbody
GO:0030877 beta-catenin destruction complex
GO:0031258 lamellipodium membrane
GO:0045171 intercellular bridge
GO:0045295 gamma-catenin binding
GO:0045595 regulation of cell differentiation
GO:0045732 positive regulation of protein catabolic process
GO:0048471 perinuclear region of cytoplasm
GO:0090090 negative regulation of canonical Wnt signaling pathway
GO:0090630 activation of GTPase activity
GO:0098794 postsynapse

Diseases

Show/Hide Table
Disease IDSourceNameDescription
618677 OMIMCortical dysplasia, complex, with other brain malformations 10 (CDCBM10)An autosomal recessive disorder of aberrant neuronal migration during brain development. CDCBM10 is clinically characterized by onset in infancy of global developmental delay, impaired intellectual development, seizures, inability to ambulate, and absent language. Brain imaging shows lissencephaly, cortical dysplasia, subcortical heterotopia, and paucity of white matter. The disease is caused by variants affecting the gene represented in this entry.
617169 OMIMSotos syndrome 3 (SOTOS3)A form of Sotos syndrome, a childhood overgrowth syndrome characterized by prenatal and postnatal overgrowth, developmental delay, mental retardation, advanced bone age, and abnormal craniofacial morphology. SOTOS3 patients do not have advanced bone age, hypotonia, seizures, or autism. SOTOS3 transmission pattern is consistent with autosomal recessive inheritance. The disease is caused by variants affecting the gene represented in this entry.